Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
3.
Nephron ; 70(3): 287-95, 1995.
Article in English | MEDLINE | ID: mdl-7477615

ABSTRACT

Phosphorus (Pi) retention linked to chronic renal failure (CRF) favors secondary hyperparathyroidism (HPT). Reduction of Pi and protein intake has been shown to prevent the development of HPT in CRF. The aim of the present study was to assess in patients with advanced CRF the long-term effects on phosphate and calcium metabolism of a low-Pi (5-7 mg/kg/day), low-protein (0.4 g/kg/day) diet providing 300 mg/day calcium (Ca) and supplemented with amino acids and ketoacids, Ca carbonate (400-800 mg/day) and vitamin D2 (1,000 IU/day). Twenty-nine patients with advanced CRF (glomerular filtration rate (GFR) 13.7 +/- 4.5 ml/min) were selected for the study, on the basis of a follow-up of a least 2 years and a satisfactory compliance to the prescribed diet. At the start of the study, biological evidence of HPT was present with increased plasma PTH concentration (144 +/- 95 pg/ml), increased plasma Pi (1.57 +/- 0.33 mmol/l), an increase in alkaline phosphatase activity and plasma osteocalcin concentration. Plasma PTH concentration was positively correlated with plasma Pi and inversely with plasma Ca concentrations and GFR. Pi and protein restriction induced a significant correction of HPT within 3 months after starting the diet. After 2 years of diet, despite the diminution of GFR (11.1 +/- 3.7 ml/min, p < 0.0001), plasma PTH was still lower than at the start of the diet (88 +/- 57 pg/ml, p < 0.01), as was plasma Pi (1.32 +/- 0.24 mmol/l, p < 0.001), total plasma Ca being higher (p < 0.01). Plasma PTH levels were correlated only to plasma Ca concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Calcitriol/blood , Calcium/administration & dosage , Dietary Proteins/administration & dosage , Hyperparathyroidism, Secondary/diet therapy , Kidney Failure, Chronic/complications , Phosphorus/administration & dosage , Adult , Aged , Calcium/blood , Calcium/pharmacokinetics , Calcium Carbonate/administration & dosage , Creatinine/blood , Female , Humans , Hyperparathyroidism, Secondary/blood , Hyperparathyroidism, Secondary/etiology , Intestinal Absorption , Kidney/physiopathology , Kidney Failure, Chronic/blood , Male , Middle Aged , Parathyroid Hormone/blood , Phosphates/blood , Phosphates/pharmacokinetics , Phosphates/urine , Retrospective Studies , Time Factors
4.
Nephrol Dial Transplant ; 10(6): 821-4, 1995.
Article in English | MEDLINE | ID: mdl-7566610

ABSTRACT

In eight patients remaining acidotic after more than 1 year of bicarbonate haemodialysis, we studied the effect of correcting the chronic metabolic acidosis using acetate-free biofiltration for 4 months on the course of secondary hyperparathyroidism. An AN69 capillary membrane was employed with a bicarbonate infusion rate initially set at 1.8 l/h in all patients and then adjusted in each one to obtain a predialysis bicarbonate of > or = 23 mmol/l. Standard blood chemistry parameters were determined every 2 weeks. Measurements of PTH, calcifediol and calcitriol, as well as calcium-PTH curves were determined at the beginning and end of the study. While acetate-free biofiltration appears to be an adequate technique for the correction of chronic metabolic acidosis when bicarbonate dialysis fails, this study indicates that it does not influence secondary hyperparathyroidism in haemodialysed patients. The level of intact PTH did not vary significantly and the calcium-PTH curves at 0 and 4 months were superimposable with no significant differences in the set point and the slope of the curves.


Subject(s)
Acidosis/therapy , Calcium/blood , Hemofiltration , Hyperparathyroidism, Secondary/therapy , Parathyroid Hormone/blood , Phosphorus/blood , Renal Dialysis/adverse effects , Acidosis/blood , Acidosis/etiology , Bicarbonates , Chronic Disease , Humans , Hyperparathyroidism, Secondary/blood , Hyperparathyroidism, Secondary/complications , Infusions, Intravenous , Kidney Diseases/blood , Kidney Diseases/complications , Kidney Diseases/therapy , Renal Dialysis/methods
6.
Kidney Int ; 40(2): 238-42, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1658422

ABSTRACT

Leucocytic Na+ K+ pump activity was assessed in 20 patients with advanced renal failure. Na+ K(+)-ATPase activity was reduced when compared with the values obtained from normal subjects (101.8 +/- 48.6 versus 165.13 +/- 8.9 microM of Pi hr-1.g-1; P less than 0.001) and the mean 86Rb uptake by U 937 cells was depressed by 38% after the addition of patients' sera. Subsequently, patients were put on a diet providing 0.3 g protein/kg body weight daily and supplemented with ketoacids. After three months of dietary treatment Na+ K(+)-ATPase activity increased to 142 +/- 48.3 (P less than 0.01) and reached normal values at the sixth month (162.8 +/- 54.70 microM of Pi hr-1.g-1; P less than 0.001) whereas 86Rb uptake increased by 23 percent when compared to initial values. These data suggest that among the different mechanisms which have been advanced to explain the defects in the Na+ pump observed in uremic patients, circulating inhibitors deriving from alimentary protein intake may affect cation transport.


Subject(s)
Dietary Proteins/administration & dosage , Sodium-Potassium-Exchanging ATPase/physiology , Uremia/diet therapy , Adult , Aged , Cell Line , Female , Humans , Keto Acids/administration & dosage , Leukocytes/metabolism , Male , Middle Aged , Sodium-Potassium-Exchanging ATPase/blood , Uremia/blood
8.
Nephron ; 48(4): 315-8, 1988.
Article in English | MEDLINE | ID: mdl-3362279

ABSTRACT

Chemiluminescence (CL) emission from leukocytes was studied in 20 uremic patients after ingestion of opsonized zymosan. CL production was impaired when compared with control groups. Six months after a low-protein, low-phosphorus diet supplemented with essential amino acids and ketoanalogues (SD) was started, a significant improvement in CL production was observed. SD may be expected to decrease the susceptibility of uremic patients to bacterial infections.


Subject(s)
Dietary Proteins/administration & dosage , Leukocytes/metabolism , Uremia/blood , Adult , Aged , Female , Humans , Leukocytes/physiology , Luminescent Measurements , Male , Middle Aged , Phagocytosis , Phosphorus/administration & dosage , Urea/blood , Uremia/diet therapy , Uremia/immunology
9.
Metabolism ; 36(11): 1080-5, 1987 Nov.
Article in English | MEDLINE | ID: mdl-3312937

ABSTRACT

Ten patients with advanced renal failure (glomerular filtration rate 25 mL/min) were treated with a low phosphorus and low protein diet supplemented with ketoacid analogues. Before starting the diet and four months afterwards, a 50 g oral glucose tolerance test with a three step euglycemic insulin clamp was carried out. A dose-response curve of total body insulin sensitivity was plotted. By the fourth month, glucose tolerance had improved with significantly lower T0, T30, and T60 insulin levels. These results are attributed to the improvement in insulin action as demonstrated by the clamp technique. The dose-response curve had a distinctly higher plateau after dietary treatment, and the tissue sensitivity index to insulin (M/l ratio) was significantly improved. It is suggested that treatment of uremic patients with a low protein diet may reduce levels of a putative insulin inhibitor.


Subject(s)
Blood Glucose/metabolism , Diet , Dietary Proteins , Insulin/blood , Kidney Failure, Chronic/metabolism , Phosphorus , Adult , Aged , Female , Glucose Tolerance Test , Humans , Infusions, Intravenous , Insulin/administration & dosage , Insulin/pharmacokinetics , Male , Middle Aged , Uremia/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL